Articles by tag: BioNTech
Pfizer Inc. and BioNTech announced plans to request U.S. emergency authorization for a third booster dose of its vaccine. The release states, “Pfizer and BioNTech have seen encouraging data in the ongoing booster trial of a third dose of the current BNT162b2 vaccine. Initial data from the study demonstrate that a booster dose given 6…